Skip to main content
OpenTrials

Clinical trial condition

Colorectal Neoplasms

Explore clinical trials studying Colorectal Neoplasms. Study availability and eligibility vary by location and protocol.

4,238 public trials 880 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Neoplasms trial results

Recruiting

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

NCT06720987

Conditions
CRC (Colorectal Cancer), Colonic Diseases, Colorectal Neoplasms, +12 more
Locations
  • Mayo Clinic, Phoenix Phoenix, Arizona, United States
  • Sarah Cannon Cancer Institute at HealthONE Denver, Colorado, United States
  • Mayo Clinic, Jacksonville Jacksonville, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NCT06128551

Conditions
Adenocarcinoma, Adnexal Diseases, Appendiceal Neoplasms, +59 more
Locations
  • City of Hope Duarte, California, United States
  • UC IRVINE Health Orange, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Stanford Cancer Institute Stanford, California, United States
View all 53 locations
View Trial Details
Recruiting

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

NCT07020221

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
View all 14 locations
View Trial Details
Recruiting

A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI

NCT07543744

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • State Budgetary Healthcare Institution of the Arkhangelsk Region "Arkhangelsk Oncology Dispensary" Arkhangelsk, Russia
  • Moscow City Oncology Hospital No. 62 (MGOB 62) Istra, Russia
  • Regional Budgetary Healthcare Institution "Ivanovo Regional Oncology Dispensary" Ivanovo, Russia
  • State Budgetary Healthcare Institution of Kaluga Region "Kaluga Regional Clinical Oncology Dispensary" Kaluga, Russia
View all 26 locations
View Trial Details

Related conditions